LYEL
#3232
Lyell Immunopharma, Inc. - Common Stock
14.3 3 USD
-0.05%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.53%
Monthly Change
+3.99%
6 month change
-40.76%
Year Change
-40.76%
Previous Close
15.0 1
Open
14.3 3
Low
14.3 3
High
14.3 3
Volume
34
Financials
- Market Capitalization 334.38 M
- Employee 161
- Founded 2018
- CEO N/A
- Website www.lyell.com
- Headquarter Delaware, United States
- FIGI BBG00RNXFN14
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.92
Price to sales ratio
14.61 K
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3215 |  HELP Cybin Inc. - Common Stock | 6.70 USD | -2.47% | +14.92% | +52.27% | -25.31% | 345.93 M USD | ||
| 3228 |  CTNM Contineum Therapeutics, Inc. - Common stock | 14.62 USD | -3.75% | -2.21% | +20.53% | -4.26% | 337.71 M USD | ||
| 3234 |  IMRX Immuneering Corporation - Class A Common Stock | 5.16 USD | +0.98% | +0.98% | +20.56% | +23.15% | 333.84 M USD | ||
| 3249 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.62 USD | -5.33% | -1.49% | +19.07% | +237.23% | 328.88 M USD |
Frequently asked questions about Lyell Immunopharma, Inc. - Common Stock
What is the Lyell Immunopharma, Inc. - Common Stock stock price today?
The current price of Lyell Immunopharma, Inc. - Common Stock (LYEL) is 14.33. Over the past 24 hours, the stock has changed by -4.53%. Follow the LYEL chart for real-time price dynamics.
What is the stock ticker of Lyell Immunopharma, Inc. - Common Stock?
Lyell Immunopharma, Inc. - Common Stock trades under the ticker LYEL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Lyell Immunopharma, Inc. - Common Stock stock going up?
LYEL has changed by +2.65% over the last week, +3.99% over the last month, and -40.76% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Lyell Immunopharma, Inc. - Common Stock net income for the last quarter?
Lyell Immunopharma, Inc. - Common Stock reported net income of -24.15 M for the last quarter. The previous quarter showed -140.72 M, which means net income changed by +82.84%.
How many employees does Lyell Immunopharma, Inc. - Common Stock have?
As of the latest available data, Lyell Immunopharma, Inc. - Common Stock has 161 employees. Workforce size can provide additional context about the company's scale and operations.
What is Lyell Immunopharma, Inc. - Common Stock EBITDA?
Lyell Immunopharma, Inc. - Common Stock EBITDA is -41.93 M, and its EBITDA margin is -2.1 M%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Lyell Immunopharma, Inc. - Common Stock stock?
You can buy Lyell Immunopharma, Inc. - Common Stock (LYEL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Lyell Immunopharma, Inc. - Common Stock stock?
Investing in Lyell Immunopharma, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LYEL chart and related analysis on metatrader.com as part of your research.